Jichu yixue yu linchuang (Feb 2022)
Research progress on drug targets for anti-retinal and choroidal neovascular diseases
Abstract
The appearance of new blood vessels in the neovascular age-related macular degeneration (nAMD), diabetic retinopathy (DR),and other ocular diseases is one of the important reasons for blindness. Anti-vascular endothelial growth factor (VEGF) drugs are the current mainstream. However, some patients have poor efficacy and other adverse reactions. There is still a need to develop new drugs.
Keywords